Skip to main content

Laxity; Skin

1
Pipeline Programs
2
Companies
5
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Fitzpatrick Company
Fitzpatrick CompanyON - Waterloo
2 programs
1
Sculptra AestheticPhase 21 trial
AGE SerumN/A2 trials
Active Trials
NCT07558603Not Yet Recruiting50Est. Nov 2026
NCT07216352Not Yet Recruiting25Est. May 2026
NCT07217743Not Yet Recruiting20Est. Oct 2026
Cytrellis Biosystems
2 programs
HighThroughput Micro Coring DeviceN/A1 trial
MCDN/A1 trial
Active Trials
NCT03583918Completed50Est. Jun 2018
NCT03573271Completed30Est. Feb 2019

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Fitzpatrick CompanySculptra Aesthetic
Fitzpatrick CompanyAGE Serum
Fitzpatrick CompanyAGE Serum
Cytrellis BiosystemsMCD
Cytrellis BiosystemsHighThroughput Micro Coring Device

Clinical Trials (5)

Total enrollment: 175 patients across 5 trials

Assess Impact of Poly-L-lactic Acid on GLP1 Subjects

Start: Oct 2025Est. completion: Oct 202620 patients
Phase 2Not Yet Recruiting

Evaluate the Safety and Efficacy of AGE Serum in Post-menopausal Patients on Hormone Replacement Therapy Taking Glucagon-like Peptide-1 Agonist

Start: Apr 2026Est. completion: Nov 202650 patients
N/ANot Yet Recruiting

Evaluate the Safety and Efficacy of a Topical Serum (AGE Serum) in Improving Visible Signs of Aging

Start: Oct 2025Est. completion: May 202625 patients
N/ANot Yet Recruiting

Pivotal Study to Evaluate the Safety and Efficacy of a Micro-coring Device Treating Moderate to Severe Facial Wrinkles

Start: Mar 2018Est. completion: Feb 201930 patients
N/ACompleted
NCT03583918Cytrellis BiosystemsHighThroughput Micro Coring Device

Efficacy of Micro-excisional Skin Removal by Micro-coring Device in Treatment of Wrinkles and Laxity of Face and Neck

Start: Jun 2017Est. completion: Jun 201850 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.